Absence of BRCA1 185delAG, BRCA1 5382InsC and BRCA2 6174delT among Hereditary Breast Cancer Patients in North Sumatera, Indonesia
One causes of breast cancer is mutations in tumor suppressor genes, namely BRCA1 and BRCA2. One of the most common types of mutations is 185delAG , 5382InsC in the BRCA1 and 6174delT in the BRCA2 gene. This mutation is called the foundation mutation which the frequency were high in the Jewish Ashkenazi population. The aim of this study was to detect the frequency of founder mutation in hereditary breast cancer patients in the North Sumatran population using the PCR-RFLP method and confirmation by sequencing. The results showed that there was no mutation in the population of north sumatera, this may be due to a small number of samples or non-specific mutations occur.
Ginting S F, Syukur S, Ibrahim S,and Tjong D H, The Influence of Estradiol and HDL-Cholesterol levels on Breast Cancer in Pre-menopause and Menopause Women and Its Correlation with BRCA1 Gene C61G Mutation, American Scientific Journal for Engineering Tehnology and Sciences (ASRJETS], 38(1), (2017), pp 250-257
Sihombing B, Syukur S, Ibrahim S, Cong HD and Setyoheryanto D, Gene Expression, P53 and Bcl-2 as Markers of Prostate Cancer Progression, American Scientific Journal for Engineering Tehnology and Sciences, (ASRJETS], 35, (1), (2017), pp 8-14
D.Purnomosari, G.Pals, A.Wahyono, T.Aryandono, TW.Manuaba, SJ.Haryono, PJ.van Diest.”BRCA1 and BRCA2 germline mutation analysis in the Indonesian population.” Breast Cancer Res Treat, vol (106), pp297-304.2006
A. Kwong.”Genetic testing for hereditary breast cancer in Asia-moving forward.”Chinese Clinical Oncology, vol 5(3), pp 1-5. 2016
A. Chakraborty, D.Banerjee, J.Basak, A.Mukhopadhyay.”Absence of 185delAG and 6174delT Mutations among Breast Cancer Patients of Eastern India.” Asian Pac J Cancer Prev, vol 16(17), pp 7929-7933, 2015
H.Yazici, O.Bitisik, E.Akisik, N.Cabioglu, P.Saip, et al.” BRCA1 and BRCA2 mutations in Turkish breast/ovarian families and young breast cancer patients.”British Journal of Cancer, vol 83(6), pp 737-742, 2000
HA.Anis. “Mutations and Cancer Genesis Highlights on BRCA1 and BRCA2 Genes.”. Journal of Cancer Prevention & Current Research, vol 2(6), pp 1-2, 2015
IA.Murray, SK. Stickel, RJ. Roberts.”Sequence-specific cleavage of RNA by type II restriction enzymes.” Nucleic Acids Res, vol 38(22), pp 8257-8268, 2010.
J. Hansa, R.Kannan, SK. Ghosh.” Screening of 185delAG, 1014deGT and 3889DelAG BRCA1 Mutations in Breast Cancer Patients from North-East India.” Asian Journal of Cancer Prevention, vol 13, pp 5871-5873, 2012.
L. Jara, S.Ampuero, L.Seccia, M.Bustamante, R.Blanco, JM.Ojeda.” Analysis of 5382InsC (BRCA1) and 6174delT (BRCA2) mutations in 382 healthy Chilean women with a family history of Breast Cancer.” Breast Cancer.Biol.Res, vol 35(1), pp 1-3, 2002
HB.Rasmussen.” Gel-Electrophoresis-Principles and Basics. InTech. Pp 315-328, 2012
M. Ghanim, N. Alwan, F.MacDonald.”Low prevalence of BRCA1 and BRCA2 Common Founder Mutations among Iraqi Breast Cancer Cases and At Risk Families. JJ Cancer Sci Res. Vol 2(8), pp 047-048
MR.MacClain, KL. Nathanson, GE.Palomaki, JE.Haddow.”An evaluation of BRCA1 and BRCA2 founder mutations penetrance estimates for breast cancer among Ashkenazi Jewish women.” Genetics in Medicine, vol 7(1), pp 123-127, 2005
- There are currently no refbacks.